First-line systemic therapy in metastatic non-small cell lung cancer (mNSCLC) patients treated at National Comprehensive Cancer Network (NCCN) institutions: An analysis from the NCCN Oncology Outcomes Database Project.

被引:0
|
作者
Vandergrift, J. L.
Mamet, R.
Zornosa, C.
Reid, M. E.
Rabin, M. S.
Ettinger, D. S.
Kalemkerian, G. P.
Otterson, G. A.
Niland, J. C.
Pisters, K.
机构
[1] Natl Comprehens Canc Network, Ft Washington, PA USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[6] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[7] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[8] Arthur G James Canc Hosp, Columbus, OH USA
[9] Solove Res Inst, Columbus, OH USA
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.7634
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7634
引用
收藏
页数:1
相关论文
共 50 条
  • [22] First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly
    Losanno, Tania
    Gridelli, Cesare
    CURRENT ONCOLOGY REPORTS, 2021, 23 (10)
  • [23] First-line combination immunotherapy for metastatic non-small cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 433 - 441
  • [24] First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly
    Tania Losanno
    Cesare Gridelli
    Current Oncology Reports, 2021, 23
  • [25] Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy.
    Sun, Lova
    Davis, Christiana
    Marmarelis, Melina Elpi
    Jeffries, Seth
    Sulyok, Lydia Frenzel
    Hwang, Wei-Ting
    Singh, Aditi Puri
    Berman, Abigail T.
    Feigenberg, Steven J.
    Levin, William C.
    Bauml, Joshua
    Ciunci, Christine Agnes
    Cohen, Roger B.
    Langer, Corey J.
    Aggarwal, Charu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] GEFITINIB AS FIRST-LINE THERAPY FOR ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS IN SOUTHERN TAIWAN
    Yang, Cheng-Ta
    Hung, Jen-Yu
    Lai, Chun-Liang
    Hung, Hsin-Chia
    Lai, Yung-Fa
    Lin, Meng-Chih
    Shieh, Jiunn-Min
    Huang, Ming-Shyang
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2010, 26 (01): : 1 - 7
  • [27] Influence of antibiotic therapy (ATB) on oncological outcomes of metastatic non-small cell lung cancer (mNSCLC) patients treated with chemoimmunotherapy (CIT).
    Clark, James
    Ricciuti, Biagio
    Bolina, Anita
    Venkatraman, Deepti
    Newsom-Davis, Thomas
    Ottaviani, Diego
    Lee, Karla
    Awad, Mark M.
    Pinato, David James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] PATIENT CHARACTERISTICS AND FIRST LINE TREATMENTS AMONG MEDICARE PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC)
    Ejzykowicz, F.
    Chen, X.
    Petrilla, A.
    Schroeder, A.
    Dietz, K.
    Agatep, B.
    Burke, T.
    Lopes, G.
    VALUE IN HEALTH, 2020, 23 : S25 - S25
  • [29] Timing in adjuvant chemotherapy (CTX) initiation among women with breast cancer (BC) at National Comprehensive Cancer Network (NCCN) centers: An analysis from the NCCN Outcomes Database.
    Vandergrift, J. L.
    Niland, J. C.
    Theriault, R. L.
    Edge, S. B.
    Wong, Y.
    Loftus, L. S.
    Breslin, T. M.
    Hudis, C.
    Javid, S. H.
    Rugo, H. S.
    Silver, S. M.
    Lepisto, E. M.
    Weeks, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions
    Valle, Luca F.
    Jagsi, Reshma
    Bobiak, Sarah N.
    Zornosa, Carrie
    D'Amico, Thomas A.
    Pisters, Katherine M.
    Dexter, Elisabeth U.
    Niland, Joyce C.
    Hayman, James A.
    Kapadia, Nirav S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (02): : 360 - 367